First Ever Topical Gene Therapy Approved For “Butterfly Disease” Children

Topical gene therapy VYJUVEK approved Butterfly Disease Epidermolysis Bullosa Beremagene Geperpavec (B-VEC) EBRP

Source: Forbes.com Healthcare News - May 24, 2023 Category: Pharmaceuticals Authors: Greg Licholai, MD, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news